Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...

October saw subdued growth in the Indian pharmaceutical market (IPM), with growth remaining in the low single digits, mainly ...

The Nifty Pharma index closed on a note on Monday. Shares of Ipca Laboratories Ltd.(up 1.97 per cent), Lupin Ltd.(up 0.99 per ...

The 17th edition of the CPHI and PMEC expo showcasing the pharmaceutical industry's modernisation, innovation and ...

The 17th CPHI & PMEC India Expo, held Nov 26-28 in Greater Noida, showcases pharma innovation, sustainability, and ...

The 17th CPHI & PMEC India Expo will showcase the latest advancements in pharmaceutical modernization, innovation, and ...

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...

An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, ...

Chinese pharma giant Shanghai Pharmaceuticals is in talks with major Indian pharmaceutical companies for greater access to ...

Shares of the Lupin Ltd. traded at Rs 2095.25 on BSE at 11:10AM ... The stock commands a market value of Rs 95477.64 crore ...

In the September quarter, the pharma major’s US sales dipped sequentially to $220 million against $227 million in Q1FY25.

Mumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United ...